| 380 |
Calcium channel blockers
|
|
261: L-type calcium channel blockade leading to heart failure via decrease in cardiac contractility
|
| 731 |
All-trans retionic acid
|
|
436: Inhibition of RALDH2 causes reduced all-trans retinoic acid levels, leading to transposition of the great arteries
|
| 579 |
PF915275
|
|
348: Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory
|
| 578 |
Glycyrrhizin
|
-
Glycyrrhizin, CAS-RN: 1405-86-3, DTXSID8047006
|
348: Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory
|
| 577 |
Osilodrostat(LCI699)
|
|
349: Inhibition of 11β-hydroxylase leading to decresed population trajectory
|
| 466 |
4-biphenyl carboxylic acid
|
|
297: Inhibition of retinaldehyde dehydrogenase leads to population decline
|
| 486 |
minocycline
|
-
Minocycline, CAS-RN: 10118-90-8, DTXSID1045033
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 531 |
Kaempferol
|
-
Kaempferol, CAS-RN: 520-18-3, DTXSID7020768
|
154: Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
|
| 681 |
Prototypical stressor
|
|
211: Handbook development AOP
|
| 474 |
BIO (6-bromoindirubin-3’-oxime)
|
|
410: GSK3beta inactivation leading to increased mortality via defects in developing inner ear
|
| 471 |
WNT2
|
|
298: Increase in reactive oxygen species (ROS) leading to human treatment-resistant gastric cancer
|
| 470 |
Wnt
|
|
298: Increase in reactive oxygen species (ROS) leading to human treatment-resistant gastric cancer
|
| 469 |
Vinblastine sulfate
|
-
Vinrosidine sulfate (1:x), CAS-RN: 18556-44-0, DTXSID7047853
|
106: Chemical binding to tubulin in oocytes leading to aneuploid offspring
|
| 468 |
SB-210661
|
|
297: Inhibition of retinaldehyde dehydrogenase leads to population decline
|
| 532 |
Dodecylbenzene sulfonate
|
|
154: Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
|
| 533 |
Dibefurin
|
|
154: Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
|
| 534 |
Ascomycin
|
|
154: Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
|
| 461 |
Disulphiram
|
|
297: Inhibition of retinaldehyde dehydrogenase leads to population decline
|
| 455 |
Potassium bromate
|
-
Potassium bromate, CAS-RN: 7758-01-2, DTXSID6020195
|
296: Oxidative DNA damage leading to chromosomal aberrations and mutations
|
| 648 |
work stress
|
|
403: combined unhealthy lifestyle factors leading to metabolic syndrome
|
| 456 |
Cadmium chloride
|
-
Cadmium chloride, CAS-RN: 10108-64-2, DTXSID6020226
|
296: Oxidative DNA damage leading to chromosomal aberrations and mutations
|
| 545 |
Carbenoxolone
|
-
Carbenoxolone, CAS-RN: 5697-56-3, DTXSID4022733
|
348: Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory
|
| 541 |
psychosocial stress
|
|
403: combined unhealthy lifestyle factors leading to metabolic syndrome
|
| 463 |
Citral
|
|
297: Inhibition of retinaldehyde dehydrogenase leads to population decline
|
| 535 |
1,5-dibenzoyloxymethyl-norcantharidin
|
|
154: Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
|